AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
179 hedge funds and large institutions have $2.29B invested in Aerie Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 29
2% less funds holding
Funds holding: 182 → 179 (-3)
Holders
179
Holding in Top 10
11
Calls
$28.9M
Puts
$10.1M
Top Buyers
| 1 | +$28M | |
| 2 | +$19M | |
| 3 | +$14.1M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.4M |
Top Sellers
| 1 | -$29.1M | |
| 2 | -$27.7M | |
| 3 | -$10.1M | |
| 4 |
DM
Deerfield Management
New York
|
-$8.88M |
| 5 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
-$8.25M |